391 related articles for article (PubMed ID: 32325421)
1. Increased expression of CD8 marker on T-cells in COVID-19 patients.
Ganji A; Farahani I; Khansarinejad B; Ghazavi A; Mosayebi G
Blood Cells Mol Dis; 2020 Jul; 83():102437. PubMed ID: 32325421
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 pneumonia: CD8
Jiang Y; Wei X; Guan J; Qin S; Wang Z; Lu H; Qian J; Wu L; Chen Y; Chen Y; Lin X
Clin Immunol; 2020 Sep; 218():108516. PubMed ID: 32574709
[TBL] [Abstract][Full Text] [Related]
3. T-Cell Subset Counts in Peripheral Blood Can Be Used as Discriminatory Biomarkers for Diagnosis and Severity Prediction of Coronavirus Disease 2019.
Jiang M; Guo Y; Luo Q; Huang Z; Zhao R; Liu S; Le A; Li J; Wan L
J Infect Dis; 2020 Jun; 222(2):198-202. PubMed ID: 32379887
[TBL] [Abstract][Full Text] [Related]
4. The changes of the peripheral CD4+ lymphocytes and inflammatory cytokines in Patients with COVID-19.
Sun HB; Zhang YM; Huang LG; Lai QN; Mo Q; Ye XZ; Wang T; Zhu ZZ; Lv XL; Luo YJ; Gao SD; Xu JS; Zhu HH; Li T; Wang ZK
PLoS One; 2020; 15(9):e0239532. PubMed ID: 32976531
[TBL] [Abstract][Full Text] [Related]
5. Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses.
Zhou R; To KK; Wong YC; Liu L; Zhou B; Li X; Huang H; Mo Y; Luk TY; Lau TT; Yeung P; Chan WM; Wu AK; Lung KC; Tsang OT; Leung WS; Hung IF; Yuen KY; Chen Z
Immunity; 2020 Oct; 53(4):864-877.e5. PubMed ID: 32791036
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for redetectable positivity in recovered COVID-19 children.
Peng D; Zhang J; Ji Y; Pan D
Pediatr Pulmonol; 2020 Dec; 55(12):3602-3609. PubMed ID: 33049115
[TBL] [Abstract][Full Text] [Related]
7. Abnormal immunity of non-survivors with COVID-19: predictors for mortality.
Zhao Y; Nie HX; Hu K; Wu XJ; Zhang YT; Wang MM; Wang T; Zheng ZS; Li XC; Zeng SL
Infect Dis Poverty; 2020 Aug; 9(1):108. PubMed ID: 32746940
[TBL] [Abstract][Full Text] [Related]
8. Single-cell landscape of immunological responses in patients with COVID-19.
Zhang JY; Wang XM; Xing X; Xu Z; Zhang C; Song JW; Fan X; Xia P; Fu JL; Wang SY; Xu RN; Dai XP; Shi L; Huang L; Jiang TJ; Shi M; Zhang Y; Zumla A; Maeurer M; Bai F; Wang FS
Nat Immunol; 2020 Sep; 21(9):1107-1118. PubMed ID: 32788748
[TBL] [Abstract][Full Text] [Related]
9. Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.
Urra JM; Cabrera CM; Porras L; Ródenas I
Clin Immunol; 2020 Aug; 217():108486. PubMed ID: 32479985
[TBL] [Abstract][Full Text] [Related]
10. A Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T Lymphocytes.
Qiu L; Jiao R; Zhang A; Chen X; Ning Q; Fang F; Zeng F; Tian N; Zhang Y; Huang Y; Sun Z; Dhuromsingh M; Li H; Li Y; Xu R; Chen Y; Luo X
Pediatr Infect Dis J; 2020 Jul; 39(7):e87-e90. PubMed ID: 32379199
[TBL] [Abstract][Full Text] [Related]
11. Decreased T cell populations contribute to the increased severity of COVID-19.
Liu R; Wang Y; Li J; Han H; Xia Z; Liu F; Wu K; Yang L; Liu X; Zhu C
Clin Chim Acta; 2020 Sep; 508():110-114. PubMed ID: 32405080
[TBL] [Abstract][Full Text] [Related]
12. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z
JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595
[TBL] [Abstract][Full Text] [Related]
13. Immunological features of coronavirus disease 2019 in patients with cancer.
Thibaudin M; Fumet JD; Bon M; Hampe L; Limagne E; Ghiringhelli F
Eur J Cancer; 2020 Nov; 139():70-80. PubMed ID: 32977223
[TBL] [Abstract][Full Text] [Related]
14. Systemically comparing host immunity between survived and deceased COVID-19 patients.
Wang F; Hou H; Yao Y; Wu S; Huang M; Ran X; Zhou H; Liu Z; Sun Z
Cell Mol Immunol; 2020 Aug; 17(8):875-877. PubMed ID: 32541836
[No Abstract] [Full Text] [Related]
15. Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients.
Haghjooy Javanmard S; Vaseghi G; Manteghinejad A; Nasirian M
J Glob Antimicrob Resist; 2020 Sep; 22():862-863. PubMed ID: 32810639
[TBL] [Abstract][Full Text] [Related]
16. Impaired Cytotoxic CD8
Westmeier J; Paniskaki K; Karaköse Z; Werner T; Sutter K; Dolff S; Overbeck M; Limmer A; Liu J; Zheng X; Brenner T; Berger MM; Witzke O; Trilling M; Lu M; Yang D; Babel N; Westhoff T; Dittmer U; Zelinskyy G
mBio; 2020 Sep; 11(5):. PubMed ID: 32948688
[TBL] [Abstract][Full Text] [Related]
17. High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19.
Schub D; Klemis V; Schneitler S; Mihm J; Lepper PM; Wilkens H; Bals R; Eichler H; Gärtner BC; Becker SL; Sester U; Sester M; Schmidt T
JCI Insight; 2020 Oct; 5(20):. PubMed ID: 32937615
[TBL] [Abstract][Full Text] [Related]
18. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.
Grifoni A; Weiskopf D; Ramirez SI; Mateus J; Dan JM; Moderbacher CR; Rawlings SA; Sutherland A; Premkumar L; Jadi RS; Marrama D; de Silva AM; Frazier A; Carlin AF; Greenbaum JA; Peters B; Krammer F; Smith DM; Crotty S; Sette A
Cell; 2020 Jun; 181(7):1489-1501.e15. PubMed ID: 32473127
[TBL] [Abstract][Full Text] [Related]
19. Immune characteristics of severe and critical COVID-19 patients.
Yang L; Gou J; Gao J; Huang L; Zhu Z; Ji S; Liu H; Xing L; Yao M; Zhang Y
Signal Transduct Target Ther; 2020 Aug; 5(1):179. PubMed ID: 32868756
[No Abstract] [Full Text] [Related]
20. The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
Akbari H; Tabrizi R; Lankarani KB; Aria H; Vakili S; Asadian F; Noroozi S; Keshavarz P; Faramarz S
Life Sci; 2020 Oct; 258():118167. PubMed ID: 32735885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
